International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.15161678
Original Research Article
Predictors for Conversion to Open Appendicectomy in Patients Undergoing Laparoscopic Appendicectomy for Acute Appendicitis
Published
April 2, 2025
Abstract

Background: Laparoscopic appendicectomy (LA) is widely preferred for acute appendicitis due to reduced postoperative pain, faster recovery, and lower wound infection rates. However, conversion to open appendicectomy (OA) may occur due to intraoperative challenges. Identifying preoperative predictors of conversion could optimize surgical planning and patient outcomes. Objective: This study aimed to identify preoperative factors predicting conversion from LA to OA in patients with acute appendicitis. Methods: A prospective study was conducted at SS Institute of Medical Sciences and Hospital, Davangere, from January 2023 to December 2024. Sixty patients undergoing LA were evaluated. Parameters including age, sex, comorbidities, ASA grading, Tzanaki’s score, leukocyte count, and ultrasound findings were analyzed. Conversion rates and associated factors were assessed using chi-square tests, with significance set at p2 (88.89% conversion, p=0.001), Tzanaki’s score ≤9 (52.38% conversion, p=0.02), and leukocyte count >12,000/mm³ (36% conversion, p=0.02). Sex showed no significant association (p=0.95). Conclusion: Preoperative factors such as advanced age, comorbidities, higher ASA grade, lower Tzanaki’s score, and leukocytosis reliably predict conversion to OA. These findings suggest a preoperative scoring system could guide surgical approach selection, reducing operative time and costs.

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
1602 Views
275 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved